Protein in saliva promises new diagnostic methods

Blood poisoning, or sepsis, affects about 0.2 percent of the population. It is a serious condition that can lead to septic shock, one of the most common causes of death at Swedish intensive care units. There is therefore a great need for early identification of potentially critical cases among patients.

SuPAR a good marker

The protein suPAR can be used as a marker of blood poisoning. This is shown in a dissertation written by Anna Gustafsson, a doctoral candidate at Malmö University. Gustafsson also found that the protein correlates with the so-called SOFA score, a measure of organ failure that is used in cases of blood poisoning. The protein could thus be used to identify patients who risk developing serious disease.

“Today a number of analyses are put together to identify these patients. It would be much easier and quicker to use suPAR, because only one sample is needed,” she says.

Opens new avenues
Gustafsson is also the first researcher to study the occurrence of suPAR in saliva and has found that the concentration of the protein is ten times higher than in the blood.

“We know that saliva reflects the composition of blood. The fact that suPAR in the blood can indicate cancer, diabetes, and other serious diseases means that our findings could open entirely new avenues for tracking various diseases in saliva,” says Gustafsson.

Using saliva instead of blood samples is of great value in screening studies, as samples can be acquired with little bother to patients, who in fact can take the sample themselves at home.

Treatment with peptides
Medical care needs not only better diagnostic methods but also more effective treatment for blood poisoning. In her research Gustafsson has studied how antimicrobial peptides, AMPs, affect two different bacterial toxins, LPS and LTA.

“The results show that AMPs moderate the immune defense’s reaction to LPS but strengthen the reaction to LTA. This is a truly unexpected finding, which hypothetically could mean that peptide treatment of LTA might aggravate the condition,” says Gustafsson.

For further information please contact Anna Gustafsson; Telephone: +46 40-66 57416 or mobile phone: +46 70 – 53 46 645 or E-mail: anna.gustafsson@mah.se

Media Contact

Charlotte Löndahl Bechmann idw

More Information:

http://www.vr.se

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors